Reliance Life Sciences offers Temozolomide Pharmaceutical Formulation in Capsule Form. Reliance Life Sciences supplies Biopharmaceuticals, Plasma Proteins, Biosimilars, Pharmaceuticals, Oncology Products, Steroids, Hormones, Peptides, Formulations, Regenerative Medicine, etc. The Temozolomide Pharmaceutical Formulation in Capsule Form is a prodrug, orally administered alkylating agent of the imidazotetrazine class, rapidly and completely absorbed and, at physiological pH, spontaneously hydrolyzed into the active metabolite. Temozolomide capsules are indicated for the treatment of adult patients with newly diagnosed glioblastoma multiforme concomitantly with radiotherapy and then as maintenance treatment. Temozolomide capsules are indicated for the treatment of adult patients with refractory anaplastic astrocytoma, i.E. Patients who have experienced disease progression on a drug regimen containing nitrosourea and procarbazine. These capsules of model name TemoRel is available as capsules of 20, 100 and 250 mg.
